204 related articles for article (PubMed ID: 19308726)
21. Regulation of estrogen sulfotransferase expression by confluence of MCF10A breast epithelial cells: role of the aryl hydrocarbon receptor.
Fu J; Fang H; Paulsen M; Ljungman M; Kocarek TA; Runge-Morris M
J Pharmacol Exp Ther; 2011 Nov; 339(2):597-606. PubMed ID: 21828262
[TBL] [Abstract][Full Text] [Related]
22. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
Aka JA; Zerradi M; Houle F; Huot J; Lin SX
Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
[TBL] [Abstract][Full Text] [Related]
23. The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta?
Thornton MJ; Nelson LD; Taylor AH; Birch MP; Laing I; Messenger AG
J Invest Dermatol; 2006 Sep; 126(9):2010-8. PubMed ID: 16691199
[TBL] [Abstract][Full Text] [Related]
24. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
Wen W; Ren Z; Shu XO; Cai Q; Ye C; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):917-20. PubMed ID: 17507616
[TBL] [Abstract][Full Text] [Related]
25. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells.
Spink DC; Katz BH; Hussain MM; Pentecost BT; Cao Z; Spink BC
Carcinogenesis; 2003 Dec; 24(12):1941-50. PubMed ID: 12970067
[TBL] [Abstract][Full Text] [Related]
26. ERα phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells.
Lin S; Lin CJ; Hsieh DP; Li LA
Lung Cancer; 2012 Mar; 75(3):285-92. PubMed ID: 21920623
[TBL] [Abstract][Full Text] [Related]
27. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
28. Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor α transactivation.
Ahmed S; Wang A; Celius T; Matthews J
Toxicol Sci; 2014 Mar; 138(1):89-103. PubMed ID: 24299737
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of enzymes involved in local estradiol synthesis in chronic obstructive pulmonary disease.
Konings GFJ; Reynaert NL; Delvoux B; Verhamme FM; Bracke KR; Brusselle GG; Romano A; Vernooy JHJ
Mol Cell Endocrinol; 2017 Mar; 443():23-31. PubMed ID: 27940297
[TBL] [Abstract][Full Text] [Related]
30. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer.
Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A
Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582
[TBL] [Abstract][Full Text] [Related]
31. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
32. Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: a source of excessive hydroxy-estrogens and ROS?
Hevir N; Ribič-Pucelj M; Lanišnik Rižner T
Mol Cell Endocrinol; 2013 Mar; 367(1-2):74-84. PubMed ID: 23277161
[TBL] [Abstract][Full Text] [Related]
33. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
35. Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.
Ren X; Wu X; Hillier SG; Fegan KS; Critchley HO; Mason JI; Sarvi S; Harlow CR
J Steroid Biochem Mol Biol; 2015 Jun; 150():54-63. PubMed ID: 25817828
[TBL] [Abstract][Full Text] [Related]
36. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
37. SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells.
Spink BC; Katz BH; Hussain MM; Pang S; Connor SP; Aldous KM; Gierthy JF; Spink DC
Carcinogenesis; 2000 Nov; 21(11):1947-57. PubMed ID: 11062153
[TBL] [Abstract][Full Text] [Related]
38. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
39. Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect.
Wang S; Aarts JM; Evers NM; Peijnenburg AA; Rietjens IM; Bovee TF
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):98-106. PubMed ID: 22138011
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens.
Margueron R; Duong V; Bonnet S; Escande A; Vignon F; Balaguer P; Cavaillès V
J Mol Endocrinol; 2004 Apr; 32(2):583-94. PubMed ID: 15072561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
